These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8466889)

  • 1. Binding of 111In-labeled LDL to platelets of normolipemic volunteers and patients with heterozygous familial hypercholesterolemia.
    Virgolini I; Li S; Qiong Y; Koller E; Banyai M; Angelberger P; Sinzinger H
    Arterioscler Thromb; 1993 Apr; 13(4):536-47. PubMed ID: 8466889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of 111In-labeled HDL to platelets from normolipemic volunteers and patients with heterozygous familial hypercholesterolemia.
    Virgolini I; Li S; Yang Q; Banyai M; Koller E; Angelberger P; Sinzinger H
    Arterioscler Thromb; 1992 Jul; 12(7):849-61. PubMed ID: 1319736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia.
    Virgolini I; Koller E; Li S; Yang Q; Banyai M; Rauscha F; Pidlich J; Pirker W; Sinzinger H
    Atherosclerosis; 1993 Sep; 102(2):217-26. PubMed ID: 8251008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of iodine-123 low-density lipoprotein (LDL) and indium-111 LDL binding to mononuclear cells of healthy normolipaemic controls and patients with heterozygous familial hypercholesterolaemia.
    Banyai M; Lupattelli G; Li SR; Pongratz S; Yang Q; Böck P; Angelberger P; Virgolini I
    Eur J Nucl Med; 1994 Jul; 21(7):634-9. PubMed ID: 7957349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia.
    Maugeais C; Ouguerram K; Frénais R; Maugère P; Charbonnel B; Magot T; Krempf M
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1679-86. PubMed ID: 11297603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia.
    Nofer JR; Tepel M; Kehrel B; Wierwille S; Walter M; Seedorf U; Zidek W; Assmann G
    Circulation; 1997 Mar; 95(6):1370-7. PubMed ID: 9118502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD
    Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia.
    Geiss HC; Schwandt P; Parhofer KG
    Exp Clin Endocrinol Diabetes; 2002 Jun; 110(4):182-7. PubMed ID: 12058342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Native and modified low-density-lipoprotein interaction with human platelets in normal and homozygous familial-hypercholesterolaemic subjects.
    Shmulewitz A; Brook JG; Aviram M
    Biochem J; 1984 Nov; 224(1):13-20. PubMed ID: 6508753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
    Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
    Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LDL binding sites on platelets differ from the "classical" receptor of nucleated cells.
    Pedreño J; de Castellarnau C; Cullaré C; Sánchez J; Gómez-Gerique J; Ordóñez-Llanos J; González-Sastre F
    Arterioscler Thromb; 1992 Nov; 12(11):1353-62. PubMed ID: 1420095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-modified low-density lipoproteins: studies in normal subjects and in patients with homozygous familial hypercholesterolemia.
    Aviram M
    Clin Biochem; 1987 Apr; 20(2):91-5. PubMed ID: 3608145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normalization of LDL receptor function by lymphocytes of patients with heterozygous familial hypercholesterolemia after treatment with plasma cholesterol lowering agents.
    Cuthbert JA; East CA; Lipsky PE
    Am J Med Sci; 1989 Sep; 298(3):152-60. PubMed ID: 2552800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hypolipidemic therapy on cholesterol homeostasis in freshly isolated mononuclear cells from patients with heterozygous familial hypercholesterolemia.
    Sundberg EE; Illingworth DR
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7631-5. PubMed ID: 6584876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis.
    Nenseter MS; Narverud I; Græsdal A; Bogsrud MP; Aukrust P; Retterstøl K; Ose L; Halvorsen B; Holven KB
    J Clin Lipidol; 2013; 7(2):109-16. PubMed ID: 23415429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the presence of the 3500 mutant apolipoprotein B-100 in low density lipoprotein particles affect their atherogenicity?
    Maher VM; Gallagher JJ; Thompson GR; Myant NB
    Atherosclerosis; 1995 Nov; 118(1):105-10. PubMed ID: 8579620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemia.
    van Tits LJ; van Himbergen TM; Lemmers HL; de Graaf J; Stalenhoef AF
    Atherosclerosis; 2006 Apr; 185(2):307-12. PubMed ID: 16005883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low density lipoprotein kinetics in a family having defective low density lipoprotein receptors in which hypercholesterolemia is suppressed.
    Vega GL; Hobbs HH; Grundy SM
    Arterioscler Thromb; 1991; 11(3):578-85. PubMed ID: 2029498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indium-111-labeled low-density lipoprotein binds with higher affinity to the human liver as compared to iodine-123-low-density-labeled lipoprotein.
    Virgolini I; Angelberger P; Li SR; Koller F; Koller E; Pidlich J; Lupattelli G; Sinzinger H
    J Nucl Med; 1991 Nov; 32(11):2132-8. PubMed ID: 1941150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of simvastatin in familial hypercholesterolemia on the affinity of electronegative low-density lipoprotein subfractions to the low-density lipoprotein receptor.
    Benítez S; Ordóñez-Llanos J; Franco M; Marín C; Paz E; López-Miranda J; Otal C; Pérez-Jiménez F; Sánchez-Quesada JL
    Am J Cardiol; 2004 Feb; 93(4):414-20. PubMed ID: 14969613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.